Covista Inc. (CVSA)
| Market Cap | 4.04B +3.1% |
| Revenue (ttm) | 1.91B +9.7% |
| Net Income | 234.06M +0.8% |
| EPS | 6.39 +5.3% |
| Shares Out | 34.51M |
| PE Ratio | 18.32 |
| Forward PE | 13.93 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 382,982 |
| Open | 116.15 |
| Previous Close | 115.31 |
| Day's Range | 115.05 - 118.93 |
| 52-Week Range | 86.97 - 156.26 |
| Beta | 0.63 |
| Analysts | Strong Buy |
| Price Target | 150.00 (+28.21%) |
| Earnings Date | May 7, 2026 |
About CVSA
Covista Inc., together with its subsidiaries, provides healthcare education in the United States, Barbados, St. Kitts, and St. Maarten. It operates in three segments: Chamberlain, Walden, and Medical and Veterinary. The company offers degree and non-degree programs, including bachelor’s, master’s, and doctoral degrees; and online certificate programs for nursing, health professions, medical, and veterinary postsecondary education, counseling, business, information technology, psychology, public health, social work and human services, public adm... [Read more]
Financial Performance
In fiscal year 2025, Covista's revenue was $1.79 billion, an increase of 12.85% compared to the previous year's $1.58 billion. Earnings were $237.07 million, an increase of 73.32%.
Financial StatementsAnalyst Summary
According to 2 analysts, the average rating for CVSA stock is "Strong Buy." The 12-month stock price target is $150.0, which is an increase of 28.21% from the latest price.
News
Covista Earnings Call Transcript: Q3 2026
Enrollment growth drove record results and raised guidance, with strong performance across all segments. Strategic investments in AI, campus expansion, and partnerships, plus robust cash flow and capital allocation, position the platform for continued growth.
Covista reports Q3 adjusted EPS $1.98, consensus $1.72
Reports Q3 revenue $487.03M, consensus $474.04M. “The country needs more nurses, physicians, and behavioral health professionals than the current system is on pace to produce. Covista (CVSA) is helpin...
Covista raises FY26 adjusted EPS view to $7.95-$8.15 from $7.80-$8.00
Consensus is $7.91. Raises FY revenue view to $1.93B-$1.945B from $1.9B-$1.94B, consensus $1.92B.
Covista Third Quarter Fiscal Year 2026 Results; Raises Fiscal Year 2026 Revenue and Adjusted Earnings Per Share Guidance
CHICAGO--(BUSINESS WIRE)--Covista Inc. (NYSE: CVSA), the largest healthcare educator in the United States, today reported third quarter fiscal year 2026 results (ended Mar. 31, 2026). The Company cont...
Covista medical schools achieve 97% first-time residency attainment rate
Covista (CVSA) announced a combined 97% first-time residency attainment rate for its 2025-2026 graduating class at Ross University School of Medicine, RUSM, and American University of the Caribbean Sc...
Covista Medical Schools Achieve 97% Combined First-Time Residency Attainment Rate
CHICAGO--(BUSINESS WIRE)--Covista (NYSE: CVSA), America's largest healthcare educator, today announced a combined 97% first-time residency attainment rate* for its 2025-2026 graduating class at Ross U...
Covista Announces AI-Powered Classroom of the Future for Healthcare Education with Google Cloud
CHICAGO--(BUSINESS WIRE)--Covista (NYSE: CVSA), America's largest healthcare educator, today announced that the healthcare AI credentials Covista and Google Cloud launched together in October are now ...
Covista announces Amelia Manning as president, Chamberlain University
Covista (CVSA) announced that Amelia Manning has been named president of Chamberlain University, effective May 18. Most recently, Manning served as the Dean of Tulane University’s School of Profession...
Amelia Manning Named as the Next President of Chamberlain University
CHICAGO--(BUSINESS WIRE)--Covista (NYSE: CVSA), America's largest healthcare educator, today announced that Amelia Manning has been named president of Chamberlain University, effective May 18, 2026. M...
Covista Announces Third Quarter Fiscal Year 2026 Conference Call
CHICAGO--(BUSINESS WIRE)--Covista (the "company" or "Covista") (NYSE: CVSA), the largest healthcare educator in the United States, announced today it will release its third quarter fiscal year 2026 re...
Covista announces Betz has been named Chief Growth & Innovation Officer
Covista (CVSA) announced that Michael Betz has been named Chief Growth & Innovation Officer, expanding his responsibilities to include oversight of the company’s Marketing organization while retaining...
Covista Expands Michael Betz's Role to Chief Growth & Innovation Officer
CHICAGO--(BUSINESS WIRE)--Covista (NYSE: CVSA), America's largest healthcare educator, today announced that Michael Betz has been named Chief Growth & Innovation Officer, expanding his responsibilitie...
Covista initiated with a Buy at Truist
Truist initiated coverage of Covista (CVSA), formerly Adtalem, with a Buy rating and $130 price target The company’s clinical healthcare-focused institutions should benefit from labor shortages and up...
Covista Transcript: Investor Day 2026
Covista unveiled its 'Purpose at Scale' strategy, targeting 7%-10% revenue CAGR and 10%-14% EPS CAGR through 2029, driven by aggressive campus expansion, digital innovation, and deep employer partnerships. The company is leveraging its scale, AI integration, and disciplined capital allocation to address the U.S. healthcare workforce crisis and deliver double-digit earnings growth.
Covista Unveils Strategic Plan for Continued Momentum and Long-Term Value Creation at Investor Day
CHICAGO--(BUSINESS WIRE)--Covista (the "company" or "Covista") (NYSE: ATGE), today will host its Investor Day beginning at 9 a.m. ET. Covista is America's largest healthcare educator, serving more tha...
Ross University School of Medicine Welcomes New Dean
CHICAGO--(BUSINESS WIRE)--Covista (NYSE: ATGE), America's largest healthcare educator, today announced Cheryl Holmes, M.D., a fellow of the Royal College of Physicians of Canada with a master's degree...
Adtalem Global Education Becomes Covista
CHICAGO--(BUSINESS WIRE)--Adtalem Global Education (NYSE: ATGE) today announced it is changing its name to Covista, marking the culmination of a four-year transformation to become America's largest he...
Covista Earnings Call Transcript: Q2 2026
Enrollment and revenue grew strongly across all segments, with Walden and Medical/Vet leading gains. Adjusted EPS guidance was raised to 17%-20% growth, and a new $750M share repurchase authorization was announced.
Adtalem Global Education Second Quarter Fiscal Year 2026 Results; Raises Fiscal Year 2026 Adjusted Earnings Per Share Guidance
CHICAGO--(BUSINESS WIRE)--Adtalem Global Education Inc. (NYSE: ATGE), the largest healthcare educator in the United States, today reported second quarter fiscal year 2026 results (ended Dec. 31, 2025)...
BetterInvesting™ Magazine Update on Adtalem Global Education (NYSE: ATGE) and Trex Company (NYSE: TREX)
TROY, Mich., Jan. 13, 2026 /PRNewswire/ -- Adtalem Global Education Inc.'s recent report has investors wondering if the company's stock is fairly valued.
Adtalem Global Education Announces Second Quarter Fiscal Year 2026 Conference Call
CHICAGO--(BUSINESS WIRE)--Adtalem Global Education Inc. (NYSE: ATGE), the largest healthcare educator in the United States, announced today it will release its second quarter fiscal year 2026 results ...
Adtalem Completes $150 Million Share Repurchase Program; Board Authorizes New $750 Million Program
CHICAGO--(BUSINESS WIRE)--Adtalem Global Education Inc. (NYSE: ATGE), America's largest healthcare educator, today announced the completion of its $150 million share repurchase program, under which th...
Covista Transcript: AGM 2025
The meeting confirmed a quorum, elected all ten director nominees, ratified the auditor with 98% approval, and approved executive compensation with over 86% support. Shareholders participated virtually, and results will be filed with the SEC.
Adtalem Accelerates $150 Million Share Repurchase Program
CHICAGO--(BUSINESS WIRE)--Company to actively deploy share repurchase authorization reflecting confidence in company's fundamental strength.
Adtalem Global Education Inc. Investigated for Securities Fraud Violations - Contact the DJS Law Group to Discuss Your Rights – ATGE
LOS ANGELES--(BUSINESS WIRE)--Adtalem Global Education Inc. Investigated for Securities Fraud Violations - Contact the DJS Law Group to Discuss Your Rights – ATGE.